Are you ready to learn about the latest breakthroughs in digital pathology? Join Deep Bio at booth #3445 and discover how DeepDxยฎ Prostate is empowering pathologists to diagnose and treat prostate can...
SEOUL, SOUTH KOREA (PRWEB)ย MARCH 14, 2023 Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics support software shared three research abstracts at the United States and Canad...
Deep Bio, a leading AI biotech dedicated to cancer diagnosis, and Visiopharm, a world leader in AI-powered image analysis and tissue mining for research and diagnostics, announced a strategic partners...
A CASE STUDY OF DEEPDXยฎ PROSTATE FROM DEEP BIO DEEPDXยฎ PROSTATE FROM DEEP BIO DeepDxยฎ Prostate is a clinically validated and CEmarked AI-based image analysis algorithm for prostate core needle biopsy ...
Deep Bio: Enhanced security and reliability through adherence to the globally recognized information security standards SEOUL, SOUTH KOREA (PRWEB)ย OCTOBER 27, 2022 Deep Bio, a pioneer in medical AI fo...
SEOUL, SOUTH KOREA (PRWEB) AUGUST 16, 2022 Deep Bio, a pioneer in medical AI for pathologic cancer diagnostics, announced that it has been recently granted Medical Device Single Audit Program (MDSAP) ...
DeepDxยฎ prostate algorithm results shown in the HALO APยฎ platform. Deep Bio successfully integrates DeepDxยฎ Prostate algorithm into HALO APยฎ platform from Indica Labs SEOUL, South Koreaย andย ALBUQUERQU...
SEOUL, SOUTH KOREA (PRWEB) JULY 25, 2022 Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics software, announced that its AI solution for grading the severity of prostate ca...